Skip to main content
EnglishEN
European Commission logo print header

A Clinical Decision Support system based on Quantitative multimodal brain MRI for personalized treatment in neurological and psychiatric disorders

Project description

DEENESFRITPL

MRI-based framework improves diagnosis of neurological disorders

Magnetic resonance imaging (MRI) is the standard imaging method for the diagnosis and monitoring of many neurological diseases such as multiple sclerosis. However, its application in clinical practice is primarily limited to visually identifying major tissue abnormalities, rather than subtle ones. The key objective of the EU-funded CDS-QUAMRI project is to develop a clinical decision support system that harnesses the power of MRI in the diagnosis of neurological and psychiatric disorders, which often lacks objective criteria. The consortium will integrate different MRI modalities and machine-learning into a single framework. The system will initially focus on major depression and multiple sclerosis, with a view to serving as a foundation for future clinical decision-making in neuroscience.

Objective

A large number of neurological and psychiatric disorders lack objective criteria for primary diagnoses, early differential diagnosis with regard to subtypes in treatment response and disease progression or effective therapy monitoring resulting in a tremendous negative socio-economic impact. Scientific studies based on advanced MRI methods indicate that related patients show specific subtle changes in multiple MRI readouts that are only detectable by quantitative approaches. Existing tools for MRI data analysis are largely insufficient to maximise the use of advanced modality based, diverse and complex MRI data with deficiencies existing mainly in interoperability as well as data organisation, integration, analysis and exploitation in clinical decision making.
Hence, the development of a clinical decision support system for neurological and psychiatric disorders is envisioned that is based on multimodal quantitative magnetic resonance imaging, advanced feature extraction and multi-parametric classification. To that the quantitative analysis of structural, functional and metabolic MRI data (11 modalities) shall be fully integrated into a single software framework for the first time; support of large data, interoperability and access for non-expert users shall be enabled and a machine learning based classification module shall be developed. The quantification and feature extraction algorithms for metabolic, perfusion, diffusion and functional imaging shall be enhanced to access the full information content of the data independent of vendor specific scan protocols as required for future use in diagnostics, stratification and monitoring of patients. The envisioned clinical decision support system shall be tested, optimized and demonstrated for major depression and multiple sclerosis, but can be extended to additional disorders by enabling large scale clinical trials and more widespread use in neuroscience as a basis for the future clinical decision making.

Fields of science

Programme(s)

Topic(s)

Call for proposal

H2020-PHC-2014-2015

See other projects for this call

Sub call

H2020-PHC-2014-two-stage

Funding Scheme

RIA - Research and Innovation action

Coordinator

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 636 250,00
Address
Hofgartenstrasse 8
80539 Munchen
Germany

See on map
Region
Bayern Oberbayern München, Kreisfreie Stadt
Links
Other funding
€ 0,00

Participants (6)

Share this page

Download

EC signature date 12 March 2015
Last update: 13 June 2022

My Booklet

Permalink: https://cordis.europa.eu/project/id/634541

European Union, 2023